The surge in RSV cases post-COVID-19 was influenced by increased testing and RSV genome variations. The impact of COVID-19 protocols on RSV spread showed lowered immunity after measures were relaxed, leading to a resurgence of cases.
RSV, a common virus in the U.S., has a significant disease burden in young children, older adults, and the immunocompromised. The virus is frequently encountered throughout life, with most children experiencing it by age two.
Collection
[
|
...
]